Health · 5 views
Clinical trials generate promising results for improving kidney health
The results of numerous high-impact Phase III clinical trials that could affect kidney-related medical care were presented in person at American Society of Nephrology Kidney Week 2026 , Oct. 22–25.
Summary
The results of numerous high-impact Phase III clinical trials that could affect kidney-related medical care were presented in person at American Society of Nephrology Kidney Week 2026 , Oct. 22–25. Atacicept inhibits the cytokines B-cell activating factor (BAFF, also known as B-lymphocyte stimulator, or BLyS) and a proliferation-inducing ligand (APRIL) involved in the pathogenesis of IgA nephropathy.
AI summaries can be wrong sometimes—always verify important details using the source article.
How AI & Automation are usedMore from Health
Continue reading recent Health coverage
- Adding emotion management skills to family weight treatment may help teens maintain weight lossContinue reading
- Pope Leo Cancer Update; Hep B Vaccine Trial Halted; 'Dark Nutrition' TrendContinue reading
- Open-source software standardizes tau PET image analysis for neurodegenerative disease researchContinue reading
- Tulisokibart Shows Promise in Hidradenitis SuppurativaContinue reading
Support HappeningNow
Independent AI-powered news analysis is reader-supported. Your contribution helps cover infrastructure, summaries, and continued platform development.
Support HappeningNow